Clinical Trials in Houston

Showing 921-940 of 15,366 trials

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

NCT04634916

A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.

Kidney Disease, End-StageEnd-stage Renal DiseaseArteriovenous Fistula

C. R. Bard280 participantsStarted Mar 2021

La Jolla, California, United States • San Francisco, California, United States • Jacksonville, Florida, United States +14 more locations

COMPLETEDPhase 1/2< 1 mile

Study of DF1001 in Patients With Advanced Solid Tumors

NCT04143711

DF1001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells. The study will occur in two phases. The first phase will be a dose escalation phase, enrolling patients with various types of solid tumors that express human epidermal growth factor receptor 2 (HER2). The second phase will include a dose expansion using the best dose selected from the first phase of the study. Multiple cohorts will be opened with eligible patients having either HER2 activated non-small cell lung cancer, hormone receptor (HR) positive HER2 negative metastatic breast cancer, or HER2 positive metastatic breast cancer. DF1001-001 will be administered as monotherapy or in combination; combinations are DF1001 + nivolumab, DF1001 + Nab paclitaxel, and DF1001 + sacituzumab govitecan-hziy.

Solid Tumor, Adult

Dragonfly Therapeutics270 participantsStarted Nov 2019

Irvine, California, United States • Los Angeles, California, United States • San Diego, California, United States +41 more locations

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Study of DF1001 in Patients With Advanced Solid Tumors

Find Trials by Condition in Houston

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

An Open Label Study of CM-AT for the Treatment of Children With Autism

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

A Study of Ponsegromab in People With Heart Failure

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery